Position in MRK
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$680,973,928
+$68,853,123 QoQ
Shares Held
5,299,408
+4.1% QoQ
Ownership
0.215%
of shares outstanding
% of Portfolio
1.24%
of 13F equity value
Holder Rank
#55
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 63%
Shared 0%
None 37%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026LSV ASSET MANAGEMENT holds $2,451,058,699 across 9 Drug Manufacturers - General names. MRK ranks #1 (27.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
This page
|
5,299,408 | $680,973,928 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
9,852,232 | $567,685,607 | |
| 3 | PFE |
Pfizer Inc
|
18,940,504 | $456,087,336 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
2,635,721 | $332,996,991 | |
| 5 | AMGN |
Amgen Inc
|
603,549 | $218,557,163 | |
| 6 | BIIB |
Biogen Inc.
|
444,049 | $95,941,226 | |
| 7 | OGN |
Organon & Co.
|
3,737,036 | $50,599,467 | |
| 8 | JNJ |
Johnson & Johnson
|
184,693 | $46,906,481 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $680,973,928 | 5,299,408 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $612,120,805 | 5,088,709 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $544,660,817 | 5,174,433 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $444,767,982 | 5,299,273 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $422,432,273 | 5,336,436 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $490,576,996 | 5,465,430 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $571,810,045 | 5,747,990 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $683,077,027 | 6,015,120 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $786,968,126 | 6,356,770 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $922,037,571 | 6,987,780 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $814,278,011 | 7,469,070 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $804,471,890 | 7,814,200 | Shares | Sole | 2023-11-03 | |
| 2023-06-30 | $980,289,975 | 8,495,450 | Shares | Sole | 2023-08-02 | |
| 2023-03-31 | $976,353,796 | 9,177,120 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $1,100,171,324 | 9,915,920 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $976,755,385 | 11,341,795 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $1,123,598,408 | 12,324,212 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $1,119,349,566 | 13,642,286 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $1,087,258,111 | 14,186,562 | Shares | Sole | 2022-01-28 | |
| 2021-09-30 | $1,103,048,334 | 14,685,772 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $1,112,584,697 | 14,306,091 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $746,020,298 | 9,677,259 | Shares | Sole | 2021-04-30 | |
| 2020-12-31 | $793,649,173 | 9,702,317 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $712,124,752 | 8,584,984 | Shares | Sole | 2020-10-23 | |
| 2020-06-30 | $661,896,756 | 8,559,375 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $614,406,037 | 7,985,525 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||